Introduction

HEK293 cells and extracts information on two key characteristics of CFTR. By co-expressing
Results
131
The assay 132 To obtain quantitative information about ion channel function of CFTR, we exploited Table S1 ).
166
Again, the magnitude of the effect was larger at 28°C. 
WT-CFTR
194
As expected, in cells expressing WT-CFTR, the maximal rate of Iˉ entry was significantly 195 higher after activation with forskolin, compared to control (DMSO), at both 37°C and 28°C
196
( Figure 3A ; Figure 3E WT). However, neither the presence of 10 µM VX-770 in addition to 197 forskolin during activation, nor incubation at 37°C vs. 28°C modified quenching rate 198 sufficiently to achieve statistical significance after multiple comparison correction ( Figure 3A ;
199 Figure 3E , WT, Supplementary Table S3) . Table S2 ), reflecting the severe gating defect which persists even after temperature correction.
205
Acute potentiation by VX-770 was required to detect function of the channels reaching the cell 3C; Figure 3E , F508del bar 6 vs. 3, Supplementary Table S3 ).
215
F508del-CFTR: rescue of ion channel function by the R1070W mutation
216
Forskolin activation alone was enough to reveal F508del/R1070W-CFTR channel activity
217
( Figure 3D , Supplementary Table S2 ). The maximal rate of Iˉ entry was significantly higher at
218
28°C than at 37°C ( Figure 3D ; Figure 3E F508del/R1070W, Supplementary Table S3 ).
220
The rare mutation panel progressively improving both biogenesis/membrane stability and conductance ( Figure 5A ). seen as most promising (Holguin, 2018 
322
In addition to membrane density, our assay quantifies channel function,. 2017). The very low conductance measured after baseline activation in both these mutants,
378
suggests that backbone flexibility at both these sites is required for channel opening and/or to 
Conclusions and Implications
394
The main advantage of our assay consists in providing simultaneous measurements of 
402
Describing each CF-causing mutation with two coordinates ( and GCFTR) is a concise,
403
informative way of characterizing mutations (e.g. Figure 5C ) and the effects of CFTR 404 modulators on them (e.g. Figure 5D ). Implementing the assay at early stages (compound KCl, 1.2 mM MgCl2, 5 mM HEPES, 2.5 mM CaCl2,1mM glucose, pH 7.4) was added to the 458 standard buffer, so that the final concentration of Iˉ in the extracellular medium was 100 mM.
459
Another 40 s later, a further 50 µL of a 100 mM Iˉ buffer containing 40 µM forskolin (100 mM Tables S6 and S7 
